3025 results found
The Peer Review Analysis Committee was established on 1 October 2020 under section 39 of the National Health and Medical Research Council Act 1992, to advise the NHMRC CEO on aspects of the peer review process.
As a recommended action under NHMRC’s Road Map 3: A strategic framework for improving Aboriginal and Torres Strait Islander health through research and associated Action Plan 2021–2024 Triennium, a review of the Indigenous Research Excellence Criteria (IREC) was undertaken in 2023. This included national consultation with the feedback considered by the Principal Committee Indigenous Caucus (PCIC) and a consultation report released in December 2023.
Welcome to Tracker, the National Health and Medical Research Council’s (NHMRC) fortnightly newsletter with the latest information on major activities and funding opportunities.
NHMRC is committed to improving health outcomes for regional, rural and remote communities.
A guide to the legislative and governance structure to refer to when accessing datasets from publicly funded research. This page also contains a single page summary to the guide and a consumer guide.
The fundamental framework for the ethical, humane and responsible care and use of animals for scientific purposes in Australia includes the application of the 3Rs – Replacement, Reduction and Refinement of animal use. This Information Paper provides information about the implementation of the 3Rs in Australia. For further information, please refer to the webpage about the 3Rs.
NHMRC has established the Gender Guidelines Governance Committee to advise NHMRC and the Gender Guidelines Development Committee on governance matters related to the development of national clinical practice guidelines for the care of trans and gender diverse people under 18 with gender dysphoria (Gender Guidelines).
The Australian Government has requested the National Health and Medical Research Council (NHMRC) develop new national clinical practice guidelines for the care of trans and gender diverse people under 18 with gender dysphoria (Gender Guidelines).
NHMRC has established a Governance Committee and a Guideline Development Committee to advise on the development of the clinical practice guidelines for the care of trans and gender diverse people under 18 with gender dysphoria (Gender Guidelines).
The clinical practice guidelines for the care of trans and gender diverse people under 18 with gender dysphoria (Gender Guidelines) will be developed in accordance with NHMRC’s rigorous guideline development process. This will include a multidisciplinary guideline development committee, evidence review, reference panel, public consultation and declaration and management of interests.
NHMRC recognises the importance of input from consumers and interest holders to ensure the guidelines are relevant and meaningful for trans and gender diverse young people seeking care, their families, and the clinicians who support them.
Electronic cigarettes (e-cigarettes) are battery-operated devices that heat a liquid containing chemicals (called ‘e-liquid’) to produce an aerosol that users inhale (a process known as vaping). Every e-liquid is different and usually contains a number of chemicals that can be harmful.1 E-liquids can contain nicotine, even when labelled ‘nicotine free’.1
NHMRC requires Administering Institutions (AIs) to have policies in place to support gender equity in health and medical research.
The introduction of structural priority funding in 2017 has significantly reduced disparities between women and men in the number of grants and total funding awarded.
The Centres of Research Excellence (CRE) scheme provides support for teams of researchers to pursue collaborative research and develop capacity in basic science research, clinical research, health services research and public health research.
We have developed a range of tools and resources to improve the way clinical trials are conducted and overseen in Australia. This page includes resources and information for researchers, sponsors, ethics committee members and consumers.
The Procedures and requirements for meeting NHMRC standards for clinical practice guidelines are designed to support guideline developers, including those seeking NHMRC approval, to ensure guidelines are developed to the highest standard.